Phase 3 trial results bring hope for patients with IgA nephropathy.

Lancet

Institute of Neuroscience and Physiology, University of Gothenburg, 405 30 Gothenburg, Sweden. Electronic address:

Published: September 2023

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0140-6736(23)01633-1DOI Listing

Publication Analysis

Top Keywords

phase trial
4
trial bring
4
bring hope
4
hope patients
4
patients iga
4
iga nephropathy
4
phase
1
bring
1
hope
1
patients
1

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!